ClinicalTrials.gg
CompletedNCT05506514Updated Jun 15, 2025

Heat Therapy to Accelerate Muscle Recovery

An interventional study of Water immersion in Muscle Damage, sponsored by Aspetar. Completed at 1 site in Qatar. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-15.

Sponsored by Aspetar · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

The use of cold on muscle (Ice, Cold Water Immersion - CWI or cryotherapy) is a widespread practice used by health professionals, athletes or non-athletic population in the treatment of muscle soreness and soft tissue injuries. Application of cold on muscle is well known to decrease inflammation and reduce pain perception. However, some studies in humans and animals have reported contrasted effects of cold on muscle regeneration. On the other hand, recent studies in humans suggest that passive heat exposure can impact positively muscle protein synthesis, mitochondrial content and muscle torque in different types of populations. Rodent studies comparing heat and cold modalities following a muscle injury have reported that only repeated heat exposure enhances cross sectional area, accelerate macrophage infiltration in damaged fibers and enhances satellite cells activation which led to a faster muscle regeneration. As such heat therapy may be a promising tool to accelerate recovery after muscle injury. This study will investigate the effect of three distinct thermal interventions (Hot, Cold and Thermoneutral water immersion) on human skeletal muscle regeneration after an eccentric exercise. 36 participants will be distributed in a counterbalanced way into 3 groups being immersed for 15min to 1h per day in either HEAT or COLD or NEUTRAL water for 10 days following eccentric contractions.

Read the detailed description

Background information \& study rationale Cold exposure is a therapeutic modality supposed to enhance regeneration by alleviating pain, reducing tissue metabolism and restricting swelling and inflammation process. However, in light of some recent studies in animal models and in humans, cold application on injury might delay and impair muscle regeneration. At the same time, passive heat therapy emerges as a novel powerful strategy to enhance muscle recovery. Indeed, in healthy subjects it has been shown that 1H/day of passive heat exposure during 11 days enhances muscle torque through an improvement in contractile muscle function. In an immobilization context, it was recently reported that repeated passive heat exposure may reduce muscle atrophy and induce mitochondrial adaptations.

In rats, heat exposure following chemically-induced injury has been shown to enhance muscle regeneration by increasing muscle weight and cross-sectional area compared to non-heated or cold exposed rats. Macrophage infiltration were reported to migrate to injury site earlier in heated animals compared to non-heated and icing-treated groups. In the same way, heat exposure was associated with an increase in satellite cells number in injured muscle fibers. In addition, it has been shown that ice application immediately after injury has delayed the recovery of Myosin Heavy Chain (MyHC) profile and in contrast, repeated heat application has facilitated the recovery of an uninjured MyHC profile. Interestingly, collagen fibers area and TGF-β1 (a collagen precursors) were shown to be lower in heated groups than in control and iced groups suggesting less muscle fibrosis. Animal studies suggest that heat exposure may be a potent stimulus to enhance soft tissue regeneration after injury.

Very few human studies have examined the impact of local heat exposure on regeneration after muscle injury. A recent study focusing on muscle regeneration in humans, have investigated the effects of a heat therapy protocol composed of five daily 90 minutes sessions with heating garment performed after an exercise-based injury protocol composed of 300 maximal voluntary eccentric contractions. Compared to thermoneutral intervention, heated group presented a better recovery of strength in a fatigue resistance test consisting of 28 maximal isokinetic contractions at 180°/sec at 1 and 4 days after exercise session.

Study goals and objectives The goal of the present study is to determine the effect of multiple localized hot-water or cold-water immersions on muscle regeneration.

  1. Principal research question/objective:

    • Determine if heat therapy can enhance and hasten muscle regeneration after an injury.
  2. Secondary research questions/objectives (if applicable):

    • Clarify the usefulness of cold modalities to enhance muscle regeneration after an injury.
    • Investigate how heat and cold modalities influence biochemical markers of muscle regeneration.

Methodology \& Project Duration The study will assess the effect of three distinct thermal therapies (Hot, Cold and Thermoneutral water immersion) on human skeletal muscle regeneration after a bout of electrically induced eccentric contractions. Participants will be assigned in a counterbalanced way to either HEAT or COLD or NEUTRAL group. Participants will be balanced after familiarization and baseline testing to ensure consistency between groups. Participants of all groups will complete a muscle injury protocol and will be treated with the assigned intervention immediately after injury and during the 10 following days.

Eccentric exercise protocol:

The eccentric exercise protocol will be inspired by the protocol conducted in several studies. This protocol (detailed below) is an exercise-based protocol that elicits substantially greater amounts of cytoskeletal damage compared with maximal voluntary contractions only. It allows us to better observe the impact of different therapies on the regeneration phases.

All participants will complete a familiarization week before the intervention. At the beginning of the intervention, baseline measurements will be tested for each participant involved in the study. The right leg will realize an electrically induced eccentric exercise protocol with the knee extensor muscles. The exercise protocol will consist of a total of 200 eccentric contractions: (i) 5 sets of 20 repetitions of eccentric leg extension at an angular velocity of 30°/second followed by (ii) 5 sets of 20 repetitions of eccentric leg extension at 180°/second using an isokinetic dynamometer (Biodex System 3). A 30 s break between each set and a 5 min break between the slow and fast contractions will be given. All muscle contractions will be induced by electrical stimulations (ES) without any voluntary contribution. Impulse trains (200 μs single pulse duration; 40 Hz; maximal current, 100 mA) will be delivered under manual control over two stimulation electrodes placed across the vastus lateralis muscle of the assigned leg; 5 cm from the top of the patella and; 5 cm from the anterior superior iliac spine. The subjects will be carefully instructed not to produce any voluntary muscle contraction during this phase of the exercise protocol. Electrical stimulation will begin at the initiation of downward movement of the dynamometer lever arm, and it will be turned off at the end of this downward movement. Range of motion during the eccentric exercise measurement will be set from 90° to 10°.

Thermal interventions:

Local heating, local cooling and sham intervention will be applied by immersing the legs up to the waist in a water bath. Thermal interventions will be applied 11 times during the protocol. They will be initiated 1 hour (D0) after the completion of eccentric exercise protocol and every day for 10 days (D1-2-3-4-5-6-7-8-9-10). Heat intervention (HOT) will consist of immersing the legs for 60 minutes in a hot water bath maintained at a temperature of 42°C. Cold intervention (COLD) will consist of immersing the legs for 15 minutes in a cold-water bath maintained at a temperature of 15°C. For the sham intervention (NEUTRAL), participant legs will be immersed for 30 minutes in a thermoneutral water bath maintained at a temperature of 32°C. Thermal interventions from day 1 to day 10 will be performed each day immediately after the completion of daily testing measurement.

Quadriceps muscle temperature will be monitored (during day 3) using a needle thermo-sensor. This measure aims to identify the changes in muscle temperature induced by each bath temperature at different muscle depth. The needle will be inserted to a depth of 2.5cm into the vastus lateralis of the treated leg after local anesthesia of the skin (2 mL of Xylocaine without adrenaline). Core temperature will be monitored using ingestible pills thermometer (e-Celcius, Bodycap, France). Room temperature will be set at 24° and 40% humidity to not interfere with treatment effects.

Familiarization visit:

A familiarization visit will be completed during the month preceding the baseline measurements. It will be composed of an eccentric exercise initiation protocol with 4 electrically induced eccentric contractions of quadriceps muscle at 30°/second and 4 at 180°/second. Participants will also experience a lightened version of the neuromuscular tests (4 peak twitch contractions, 3 maximal voluntary contractions, 2 EMG measurements, 5 RFD contractions, 5 contractions at 120°/second) in order to accustomed them to the testing procedure. During the familiarization visit, a consent form and a Par-Q questionnaire will also be completed and an anthropometric analysis (ISAK) will be realised by participants.

Data collection procedure:

All the tests from day 1 to day 10 will be realized before the thermal intervention to avoid any acute effect.

Complete neuromuscular testing:

A complete neuromuscular test battery will be performed at baseline (i.e. the week preceding the beginning of the intervention) and post-injury at day 10. It will be composed of an electrically evoked twitch measure, 3 maximal voluntary contractions in isometric mode, 5 contractions to assess rate of force development, an electromyographic analysis, a shear wave elastography analysis, a fatigue test and a muscle soreness evaluation of the vastus lateralis.

Intermediate neuromuscular testing:

An Intermediate neuromuscular testing will be performed at day 2 and day 4 after the eccentric exercise. The intermediate test battery will only include the electrically evoked twitch measure, 3 maximal voluntary contractions in isometric mode, 5 contractions to assess RFD, an electromyographic analysis, a shear wave elastography analysis and a muscle soreness evaluation of the vastus lateralis.

Simplified neuromuscular testing:

A simplified neuromuscular testing will be performed at day 1, 2, 3 and then every day from day 5 to day 9. It will only be composed of an electrically evoked twitch measure and a muscle soreness evaluation of the vastus lateralis.

Muscle biopsy sampling:

Biopsies of the vastus lateralis will be taken at baseline (i.e. the week preceding the beginning of the intervention) and on day 5 and 11. The biopsy taken the baseline measurement will be sampled on the contralateral leg.

Thermal imaging:

Thermal imaging of the legs will be recorded each day from day 1 to day 10 before the completion of any neuromuscular tests or biopsy.

02

Conditions studied

  • Muscle Damage
03

In context

Lead sponsor

Aspetar is the lead sponsor of 11 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy
  • Adult (18 to 45 yrs)
  • Physically active

Exclusion criteria

Exclusion Criteria:

  • to physical activity as per the Par-Q questionnaire
  • Neural, skin or muscular pathology.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
34 participants (actual)

Study arms

  • Experimental
    Hot

    1h per day of water immersion at 42ºC for 11 days

    Other: Water immersion

  • Sham comparator
    Temperate

    30min per day of water immersion at 32ºC for 11 days

    Other: Water immersion

  • Experimental
    Cold

    15min per day of water immersion at 15ºC for 11 days

    Other: Water immersion

Interventions

  • OtherWater immersion

    Comparison of 3 different water temperatures

06

What researchers measure

Primary outcomes

  1. Change in muscle strength after 2 days

    Change in maximal knee extensor isometric voluntary force (kg) 2 days after the exercise as compared to baseline

    Time frame: 2 days post exercise

  2. Change in muscle strength after 4 days

    Change in maximal knee extensor isometric voluntary force (kg) 4 days after the exercise as compared to baseline

    Time frame: 4 days post exercise

  3. Change in muscle strength after 10 days

    Change in maximal knee extensor isometric voluntary force (kg) 10 days after the exercise as compared to baseline

    Time frame: 10 days post exercise

Secondary outcomes

  1. Change in muscle fiber

    Change in the proportion of centrally nucleated muscle fiber (%) in a muscle biopsy of the vastus lateralis at 5 days post exercise as compared to baseline

    Time frame: 5 days post exercise

  2. Change in muscle fiber

    Change in the proportion of centrally nucleated muscle fiber (%) in a muscle biopsy of the vastus lateralis at 11 days post exercise as compared to baseline

    Time frame: 11 days post exercise

07

Study locations

1 site
  • Aspetar sport medicine hospital
    Doha, 0000, Qatar
08

References and documents

Publications

  • Dablainville V, Mornas A, Normand-Gravier T, Al-Mulla M, Papakostas E, Olory B, Fermin TM, Zampeli F, Nader N, Alhammoud M, Bayne F, Sanchez AMJ, Cardinale M, Candau R, Bernardi H, Racinais S. Muscle regeneration is improved by hot water immersion but unchanged by cold following a simulated musculoskeletal injury in humans. J Physiol. 2025 May 28. doi: 10.1113/JP287777. Online ahead of print. PubMed 40437768 ↗

Individual participant data

Plan to share: No — No personal identifier will be shared. All data will be anonymous

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2022 to primary completion in Apr 2024, 21 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 24, 2022
First posted
Aug 18, 2022
StartActual
Jul 14, 2022
Primary completionActual
Apr 27, 2024
CompletionActual
Apr 27, 2024
Last update
Jun 15, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05506514
Lead sponsor
Aspetar
Responsible party
Sponsor
First posted
Aug 18, 2022
Start date
Jul 14, 2022
Primary completion
Apr 27, 2024
Completion
Apr 27, 2024
Last update
Jun 15, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion